Skip to content
Disclosery

EXANE DERIVATIVES: PSA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PSA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,767 PSA shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,767 shares
    Change vs previous 13F -727 shares

    0.5% of the 13F portfolio, value $865,052.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,494 shares
    Change vs previous 13F -273 shares

    0.38% of the 13F portfolio, value $1,363,614.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,767 shares
    Change vs previous 13F +3,166 shares

    0.34% of the 13F portfolio, value $1,410,978.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 601 shares
    Change vs previous 13F +102 shares

    0.04% of the 13F portfolio, value $178,559.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 499 shares
    Change vs previous 13F -46 shares

    0.04% of the 13F portfolio, value $154,831.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 545 shares
    Change vs previous 13F +542 shares

    0.04% of the 13F portfolio, value $134,486.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $693.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 3 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $668.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).